Post Profile

Opioid Makers Funneled Millions to Patient Advocacy Groups

Opioid manufacturers funneled nearly $9 million to leading pain treatment advocacy organizations and industry groups that in turn promoted the painkillers, according to a report released Monday by Missouri Sen. Claire McCaskill (D) as part of an ongoing investigation into opioid makers. The report examines payments between 2012 and 2017 from five pharmaceutical companies, including the mak
read more


Related Posts

Opioids no better than common painkillers for treating chronic pain, study finds

Health : Chicago Tribune: Health

Doctors and patients have long assumed that opioids are uniquely powerful medicines for chronic pain, despite their risks. But it turns out that this reputation may be a myth. A government-funded study published Tuesday is among the...

Sen. Claire McCaskill to undergo breast cancer treatment

News : The Raw Story

Senator Claire McCaskill will be absent from Congress for the next three weeks as she undergoes treatment for breast cancer, the Missouri Democrat wrote in a blog post on Monday. McCaskill, who leads the Senate Special Committee on ...

A Senator Is Taking on the Pharma Companies Behind the Opioid Epidemic

News / Independent News : Mother Jones

On Tuesday, Sen. Claire McCaskill (D-Mo.) launched an investigation into how the nation's leading painkiller manufacturers fueled the current opioid crisis—the most deadly drug epidemic in US history. McCaskill requested internal sa...

Opioid makers paid millions to advocacy groups: U.S. Senate report

Health : Reuters: Health

(Reuters) - Five opioid manufacturers including OxyContin maker Purdue Pharma LP have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkil...

Report: Patient advocacy groups pushed opioids after getting industry money

Politics / US Politics : Washington Watch

Opioid manufacturers funneled millions of dollars to patient advocacy groups that in turn issued “opioid friendly” guidance and policy recommendations, a congressional report has found. Five major pharmaceutical manufacturers paid …...


Copyright © 2016 Regator, LLC